The ONCO/Reveal Multi-Cancer cfDNA Panel is a robust NGS assay that interrogates 31 genes of interest across multiple solid tumor cancer types. The panel includes UIDs† to increase sensitivity and is specifically designed for cell-free DNA samples (liquid biopsies). The assay uses proprietary Stem-Loop Inhibition-Mediated amplification (SLIMamp®) technology for efficient single-tube target enrichment.
- Streamlined single-well amplification
- High on-target, mapping, and coverage uniformity rates
- Targets 31 known lung cancer oncogenes